Ignite Creation Date:
2025-12-24 @ 12:08 PM
Ignite Modification Date:
2026-03-26 @ 3:08 PM
Study NCT ID:
NCT02398461
Status:
COMPLETED
Last Update Posted:
2018-08-22
First Post:
2015-03-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis Immediately Following a Relapse
Sponsor:
Acorda Therapeutics
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Multiple Sclerosis, Acute Relapsing | View |
Keywords: